Literature DB >> 19696414

Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants.

Timolaos Rizos1, Christian Herweh, Ekkehart Jenetzky, Christoph Lichy, Peter Arthur Ringleb, Werner Hacke, Roland Veltkamp.   

Abstract

BACKGROUND AND
PURPOSE: Thrombolysis in patients using oral anticoagulants (OAC) and in patients for whom information on OAC status is not available is frequently delayed because the standard coagulation analysis procedure in central laboratories (CL) is time-consuming. By using point-of-care (POC) coagumeters, international normalized ratio (INR) values can be measured immediately at the bedside. The accuracy and effectiveness of POC devices for emergency management in acute ischemic stroke has not been tested.
METHODS: In phase 1, the reliability of emergency INR POC measurements in comparison to CL was determined. In phase 2, patients with ischemic stroke admitted within the time frame for systemic thrombolysis and who were either using OAC or for whom information on OAC status was not available were enrolled. Patients received thrombolysis if POC INR was <or=1.5. Precision and time gain was recorded for INR as measured by POC vs CL.
RESULTS: In phase 1 (n=113), Bland-Altman analysis showed close agreement between POC and CL, and Pearson correlation was highly significant (r=0.98; P<0.01). In phase 2, 48 patients were included, of whom 70.8% were using OAC; 23 patients received thrombolysis. After subtracting the time needed for the diagnostic work-up, the net time gain was 28+/-12 minutes (mean+/-SD).
CONCLUSIONS: Measuring INR by POC in an emergency setting is sufficiently precise in OAC acute stroke patients and substantially reduces the time interval until INR values are available and therefore may hasten the initiation of thrombolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696414     DOI: 10.1161/STROKEAHA.109.562769

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

Review 1.  [New oral anticoagulants in atrial fibrillation].

Authors:  R Veltkamp; W Hacke
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

2.  Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.

Authors:  Timolaos Rizos; Ekkehart Jenetzky; Christian Herweh; Andreas Unterberg; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

3.  Stroke: Is thrombolysis safe in anticoagulated ischaemic stroke?

Authors:  Roland Veltkamp; Timolaos Rizos
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

Review 4.  [Difficult decisions in stroke therapy].

Authors:  M Endres; M Grond; W Hacke; M Ebinger; P D Schellinger; M Dichgans
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

5.  A high-urgency stroke code reduces in-hospital delays in acute ischemic stroke: a single-centre experience.

Authors:  Paolo Candelaresi; P Lattuada; C Uggetti; R Daccò; G Fontana; F Frediani
Journal:  Neurol Sci       Date:  2017-06-30       Impact factor: 3.307

Review 6.  [Appropriate treatment of acute stroke at all times and in all places : Organizational concepts and new approaches].

Authors:  J E Weber; H J Audebert
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

7.  Management of the Interventional Stroke Patient.

Authors:  Julian Bösel
Journal:  Curr Treat Options Neurol       Date:  2015-10       Impact factor: 3.598

8.  Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.

Authors:  David J Seiffge; Christopher Traenka; Alexandros Polymeris; Lisa Hert; Urs Fisch; Nils Peters; Gian Marco De Marchis; Raphael Guzman; Christian H Nickel; Philipp A Lyrer; Leo H Bonati; Dimitrios Tsakiris; Stefan Engelter
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

9.  Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.

Authors:  Robert Ploen; Li Sun; Wei Zhou; Stefan Heitmeier; Markus Zorn; Ekkehart Jenetzky; Roland Veltkamp
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-18       Impact factor: 6.200

Review 10.  [From stroke to reperfusion : How can we be faster?]

Authors:  F Härtig; J Purrucker; C Hametner; S Poli
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-12       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.